NIH Office of Technology Transfer
 | This article needs additional citations for verification. (August 2021) |
The NIH Office of Technology Transfer manages all intramural inventions from the NIH and FDA as mandated by the Federal Technology Transfer Act and related legislation. It was established in 1986 subsequent to the Federal Technology Transfer Act as a centralized group to oversee patent and license matters for all of the NIH Institutes and Centers.[1][2] The office allows both agencies to better license their work for international use.[3][4]
References[]
- ^ "FY-2014 ANNUAL REPORT" (PDF). NIH Office of Technology Transfer. Retrieved 22 August 2021.
- ^ Guston, David H. (1 February 1999). "Stabilizing the Boundary between US Politics and Science:: The Rôle of the Office of Technology Transfer as a Boundary Organization". Social Studies of Science. 29 (1): 87–111. doi:10.1177/030631299029001004. ISSN 0306-3127. Retrieved 22 August 2021.
- ^ "Partnerships for Innovation and Global Health: NIH International Technology Transfer Activities". www.iphandbook.org. Retrieved 22 August 2021.
- ^ Salicrup, Luis A. (September 2007). "NIH forges R&D partnerships in developing countries". Nature Biotechnology. 25 (9): 976–977. doi:10.1038/nbt0907-976. ISSN 1546-1696. Retrieved 22 August 2021.
External links[]
 | This United States government–related article is a stub. You can help Wikipedia by . |
Categories:
- United States government stubs
- Federal government of the United States